Royce & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXE
Anixter International Inc
AXE
|
+$64.8M |
| 2 |
Artisan Partners
APAM
|
+$56.9M |
| 3 |
Dorman Products
DORM
|
+$52.1M |
| 4 |
RPC Inc
RES
|
+$46.1M |
| 5 |
Nu Skin
NUS
|
+$42.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Myriad Genetics
MYGN
|
+$136M |
| 2 |
Cirrus Logic
CRUS
|
+$108M |
| 3 |
Pan American Silver
PAAS
|
+$88.9M |
| 4 |
Federated Hermes
FHI
|
+$72.5M |
| 5 |
POLY
Plantronics, Inc.
POLY
|
+$68.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.83% |
| 2 | Technology | 17.23% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 10.18% |
| 5 | Materials | 7.95% |
Similar funds
Royce & Associates's Q4 2014 Portfolio in Review
As of Q4 2014, Royce & Associates held 1,466 positions worth $28.8B, down 2.6% from $29.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
Royce & Associates withdrew a net $2.41B in Q4 2014, closing 155 positions and reducing 586 holdings. Its most notable exit was Strategic Education, an estimated $42.5M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Royce & Associates opened a new position in Avid Technology Inc worth $27.2M.
- Royce & Associates's largest Q4 2014 buy was Avid Technology Inc: 1,911,784 shares worth $27.2M.
- Royce & Associates added most to Anixter International Inc in Q4 2014, an estimated $64.8M increase.
- Royce & Associates's biggest Q4 2014 reduction was Myriad Genetics, cutting an estimated $136M.
- Royce & Associates fully exited Strategic Education in Q4 2014, selling an estimated $42.5M.
- Royce & Associates's ten largest holdings make up 9.5% of its $28.8B portfolio in Q4 2014.
- Royce & Associates opened 69 new positions and closed 155 in Q4 2014.
- Royce & Associates's portfolio value fell 2.6% quarter-over-quarter to $28.8B.
Based on Royce & Associates's 13F filing for Q4 2014, filed 9 Feb 2015.